Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Blood biomarkers on admission in acute traumatic brain injury: Relations to severity, CT findings and care path in the CENTER-TBI study
Endre Czeiter, Krisztina Amrein, Benjamin Gravesteijn, et al.
EBioMedicine (2020) Vol. 56, pp. 102785-102785
Open Access | Times Cited: 203

Showing 1-25 of 203 citing articles:

Traumatic brain injury: progress and challenges in prevention, clinical care, and research
Andrew I.R. Maas, David Menon, Geoffrey T. Manley, et al.
The Lancet Neurology (2022) Vol. 21, Iss. 11, pp. 1004-1060
Open Access | Times Cited: 648
Blood GFAP as an emerging biomarker in brain and spinal cord disorders
Ahmed Abdelhak, Matteo Foschi, Samir Abu‐Rumeileh, et al.
Nature Reviews Neurology (2022) Vol. 18, Iss. 3, pp. 158-172
Open Access | Times Cited: 475
Axonal marker neurofilament light predicts long-term outcomes and progressive neurodegeneration after traumatic brain injury
Neil Graham, Karl Zimmerman, Federico Moro, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 613
Open Access | Times Cited: 129
Serum Glial Fibrillary Acidic Protein: A Neuromyelitis Optica Spectrum Disorder Biomarker
Orhan Aktaş, Michael Smith, William A. Rees, et al.
Annals of Neurology (2021) Vol. 89, Iss. 5, pp. 895-910
Open Access | Times Cited: 106
Blood biomarkers for mild traumatic brain injury: a selective review of unresolved issues
Daniel B. Hier, Tayo Obafemi-Ajayi, Matthew S. Thimgan, et al.
Biomarker Research (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 93
Unique diagnostic signatures of concussion in the saliva of male athletes: the Study of Concussion in Rugby Union through MicroRNAs (SCRUM)
Valentina Di Pietro, Patrick O’Halloran, Callum N. Watson, et al.
British Journal of Sports Medicine (2021) Vol. 55, Iss. 24, pp. 1395-1404
Open Access | Times Cited: 69
Serum metabolome associated with severity of acute traumatic brain injury
Ilias Thomas, Alex M. Dickens, Jussi P. Posti, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 69
Thorough overview of ubiquitin C‐terminal hydrolase‐L1 and glial fibrillary acidic protein as tandem biomarkers recently cleared by US Food and Drug Administration for the evaluation of intracranial injuries among patients with traumatic brain injury
Kevin Wang, Firas Kobeissy, Zaynab Shakkour, et al.
Acute Medicine & Surgery (2021) Vol. 8, Iss. 1
Open Access | Times Cited: 68
Incremental prognostic value of acute serum biomarkers for functional outcome after traumatic brain injury (CENTER-TBI): an observational cohort study
Isabel R. A. Retel Helmrich, Endre Czeiter, Krisztina Amrein, et al.
The Lancet Neurology (2022) Vol. 21, Iss. 9, pp. 792-802
Open Access | Times Cited: 67
S100B, GFAP, UCH-L1 and NSE as predictors of abnormalities on CT imaging following mild traumatic brain injury: a systematic review and meta-analysis of diagnostic test accuracy
Michael Amoo, Jack Henry, Philip J. O’Halloran, et al.
Neurosurgical Review (2021) Vol. 45, Iss. 2, pp. 1171-1193
Closed Access | Times Cited: 66
Post-acute blood biomarkers and disease progression in traumatic brain injury
Virginia Newcombe, Nicholas J. Ashton, Jussi P. Posti, et al.
Brain (2022) Vol. 145, Iss. 6, pp. 2064-2076
Open Access | Times Cited: 66
The biological significance and clinical utility of emerging blood biomarkers for traumatic brain injury
Megan E. Huibregtse, Jeffrey J. Bazarian, Sandy R. Shultz, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 130, pp. 433-447
Open Access | Times Cited: 57
GFAP and S100B: What You Always Wanted to Know and Never Dared to Ask
Damir Janigro, Stefania Mondello, Jussi P. Posti, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 53
A Framework to Advance Biomarker Development in the Diagnosis, Outcome Prediction, and Treatment of Traumatic Brain Injury
Elisabeth A. Wilde, Ina-Beate Wanner, Kimbra Kenney, et al.
Journal of Neurotrauma (2022) Vol. 39, Iss. 7-8, pp. 436-457
Open Access | Times Cited: 51
Evaluation of Glial and Neuronal Blood Biomarkers Compared With Clinical Decision Rules in Assessing the Need for Computed Tomography in Patients With Mild Traumatic Brain Injury
Linda Papa, Jay G. Ladde, John F. O’Brien, et al.
JAMA Network Open (2022) Vol. 5, Iss. 3, pp. e221302-e221302
Open Access | Times Cited: 43
State of the Art of Machine Learning–Enabled Clinical Decision Support in Intensive Care Units: Literature Review
Na Hong, Chun Liu, Jianwei Gao, et al.
JMIR Medical Informatics (2022) Vol. 10, Iss. 3, pp. e28781-e28781
Open Access | Times Cited: 40
The association between inflammatory markers in blood and cerebrospinal fluid: a systematic review and meta-analysis
Frederieke Gigase, Emma Smith, Brett Collins, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 4, pp. 1502-1515
Closed Access | Times Cited: 36
Association of CSF and Serum Neurofilament Light and Glial Fibrillary Acidic Protein, Injury Severity, and Outcome in Spinal Cord Injury
Sophie Stukas, Jennifer Cooper, Jasmine Gill, et al.
Neurology (2023) Vol. 100, Iss. 12
Open Access | Times Cited: 29
Blood biomarkers for traumatic brain injury: A narrative review of current evidence
Iftakher Hossain, Niklas Marklund, Endre Czeiter, et al.
Brain and Spine (2023) Vol. 4, pp. 102735-102735
Open Access | Times Cited: 27
The game changer: UCH-L1 and GFAP-based blood test as the first marketed in vitro diagnostic test for mild traumatic brain injury
Firas Kobeissy, Rawad Daniel Arja, Jennifer C. Munoz, et al.
Expert Review of Molecular Diagnostics (2024) Vol. 24, Iss. 1-2, pp. 67-77
Open Access | Times Cited: 13
A single-cell atlas deconstructs heterogeneity across multiple models in murine traumatic brain injury and identifies novel cell-specific targets
Ruchira M. Jha, Dhivyaa Rajasundaram, Chaim Sneiderman, et al.
Neuron (2024) Vol. 112, Iss. 18, pp. 3069-3088.e4
Open Access | Times Cited: 12
Serum Neurofilament Light and Postoperative Delirium in Cardiac Surgery: A Preplanned Secondary Analysis of a Prospective Observational Study
Céline Khalifa, Annie Robert, Maximilien Cappe, et al.
Anesthesiology (2024) Vol. 140, Iss. 5, pp. 950-962
Closed Access | Times Cited: 11
Evaluation of Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase-L1 Using a Rapid Point of Care Test for Predicting Head Computed Tomography Lesions After Mild Traumatic Brain Injury in a Dutch Multi-Center Cohort
Walid Chayouâ, Koen Visser, Myrthe E. de Koning, et al.
Journal of Neurotrauma (2024) Vol. 41, Iss. 13-14, pp. e1630-e1640
Closed Access | Times Cited: 11
Early systemic insults following traumatic brain injury: association with biomarker profiles, therapy for intracranial hypertension, and neurological outcomes—an analysis of CENTER-TBI data
Chiara Robba, Francesca Graziano, Edoardo Picetti, et al.
Intensive Care Medicine (2024) Vol. 50, Iss. 3, pp. 371-384
Open Access | Times Cited: 11
Parallel Cerebrospinal Fluid and Serum Temporal Profile Assessment of Axonal Injury Biomarkers Neurofilament-Light Chain and Phosphorylated Neurofilament-Heavy Chain: Associations With Patient Outcome in Moderate-Severe Traumatic Brain Injury
Kevin Wang, David J. Barton, Leah E. McQuillan, et al.
Journal of Neurotrauma (2024) Vol. 41, Iss. 13-14, pp. 1609-1627
Closed Access | Times Cited: 9
Page 1 - Next Page

Scroll to top